Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cellular immune response to the hepatitis C virus.

¹Liver Diseases Section, NIDDK, National Institutes of Health, Bethesda, Maryland 20892-1800, USA.

Journal of Viral Hepatitis

|April 12, 2000

Summary

Hepatitis C virus (HCV) infection often leads to chronic disease, increasing risks for liver cirrhosis and cancer. Understanding early immune responses is key to developing effective vaccines and therapies for HCV.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.

Genes and immunity·2015

Same author

The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes.

Alimentary pharmacology & therapeutics·2011

Same author

Identification of a new Patr-B01 variant, Patr-B0102, by sequence-based typing in a chimpanzee (Pan troglodytes).

Tissue antigens·2009

Same author

Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes).

Tissue antigens·2008

Same author

Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles.

Tissue antigens·2008

Same author

Identification of four novel MHC-C alleles in chimpanzees.

Tissue antigens·2007

Area of Science:

Hepatology
Virology
Immunology

Background:

Hepatitis C virus (HCV) infection is typically asymptomatic during the acute phase.
Most acute HCV infections progress to chronic hepatitis.
Chronic HCV infection elevates the risk of liver cirrhosis and hepatocellular carcinoma.

Purpose of the Study:

To investigate the early virus-host interactions in Hepatitis C virus infection.
To characterize the strength and kinetics of the antiviral immune response at different disease stages.
To identify immunological correlates of viral clearance for vaccine and therapy development.

Main Methods:

Analysis of immune response kinetics in various stages of Hepatitis C virus infection.
Characterization of early virus-host interaction events.
Identification of biomarkers for viral clearance.

Main Results:

Early events in Hepatitis C virus infection kinetics influence disease outcome.
Understanding the antiviral immune response is crucial for predicting infection resolution.
Specific immune responses correlate with viral clearance in Hepatitis C virus infections.

Conclusions:

The outcome of Hepatitis C virus infection is determined by early virus-host interactions.
Characterizing the antiviral immune response is essential for developing Hepatitis C virus vaccines and therapies.
Identifying immunological correlates of viral clearance will guide future treatment strategies.

Related Experiment Videos